Free Trial

Moleculin Biotech (MBRX) Institutional Ownership

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free MBRX Stock Alerts
$4.45
+0.15 (+3.49%)
(As of 10:20 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)

Current
Institutional Ownership
Percentage
15.52%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$41.94M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$372.92K
Get MBRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MBRX Institutional Buying and Selling by Quarter

Moleculin Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600%
1/17/2024Atticus Wealth Management LLC50,001$43K0.0%N/A0.168%
5/15/2023Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407%
7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072%
4/20/2022Sigma Planning Corp57,500$102K0.0%+33.7%0.201%
2/2/2022Sigma Planning Corp43,000$80K0.0%N/A0.150%
11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947%
9/17/2021Virtu Financial LLC25,302$93K0.0%N/A0.089%
8/16/2021Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102%
8/16/2021State Street Corp59,900$220K0.0%N/A0.210%
8/13/2021Geode Capital Management LLC237,586$871K0.0%+35.9%0.835%
8/13/2021Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683%
8/12/2021XTX Topco Ltd32,997$121K0.0%N/A0.116%
8/5/2021GSA Capital Partners LLP31,120$114K0.0%N/A0.109%
5/21/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049%
5/19/2021Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102%
5/18/2021Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094%
5/18/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049%
5/14/2021Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078%
5/12/2021Northern Trust Corp50,731$207K0.0%-43.1%0.178%
5/12/2021Geode Capital Management LLC174,822$713K0.0%-40.6%0.615%
5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841%
4/27/2021Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035%
4/14/2021Taylor Cottrill Erickson & Associates Inc.16,964$69K0.0%-83.3%0.060%
2/10/2021Renaissance Technologies LLC948,503$756K0.0%+6.4%7.901%
11/13/2020Truist Financial Corp175,000$142K0.0%+25.0%0.284%
8/14/2020Bank of America Corp DE39,900$39K0.0%N/A0.066%
7/31/2020UBS Group AG47,538$46K0.0%+40.2%0.079%
5/15/2020Two Sigma Securities LLC90,062$55K0.0%+556.3%0.169%
4/21/2020Raymond James Financial Services Advisors Inc.72,546$44K0.0%+271.2%0.136%
(Data available from 1/1/2016 forward)

MBRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MBRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Armistice Capital LLC ($2.75M), Sio Capital Management LLC ($971K), and Atticus Wealth Management LLC ($43K), Walker Asset Management LLC ($32K).Learn more on MBRX's institutional investors.

What percentage of Moleculin Biotech stock is owned by institutional investors?

15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings.

Which institutional investors have been buying Moleculin Biotech stock?

The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), Atticus Wealth Management LLC ($50.00K), and Walker Asset Management LLC ($20.71K).

How much institutional buying is happening at Moleculin Biotech?

Institutional investors have bought a total of 3,278,126 shares in the last 24 months. This purchase volume represents approximately $42.39M in transactions.

Which Moleculin Biotech major shareholders have been selling company stock?

The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K).

How much institutional selling is happening at Moleculin Biotech?

Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions.


Related Companies:
This page (NASDAQ:MBRX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
[Shocking] Elon Musk’s Plan To End Banks
Crypto 101 Media